Vascular News and Research

RSS
Iconic Therapeutics completes $20 million Series B-1 equity financing

Iconic Therapeutics completes $20 million Series B-1 equity financing

St. Jude Medical's net sales increase 2% in first quarter 2014

St. Jude Medical's net sales increase 2% in first quarter 2014

Researchers explore new standard of continuity of care for stroke patients

Researchers explore new standard of continuity of care for stroke patients

Reverse Medical receives FDA IDE approval for BARREL Vascular Reconstruction Device

Reverse Medical receives FDA IDE approval for BARREL Vascular Reconstruction Device

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Students competing in Center for Medical Innovation’s Annual Bench-to-Bedside Competition win nearly $72,000

Students competing in Center for Medical Innovation’s Annual Bench-to-Bedside Competition win nearly $72,000

Two Penn researchers selected as recipients of prestigious Clinical Research Achievement Award

Two Penn researchers selected as recipients of prestigious Clinical Research Achievement Award

Abbott completes enrollment of 3 clinical trials to support approval of Absorb Bioresorbable Vascular Scaffold

Abbott completes enrollment of 3 clinical trials to support approval of Absorb Bioresorbable Vascular Scaffold

MCVI receives federal approval to launch adult heart transplant program at Memorial Regional Hospital

MCVI receives federal approval to launch adult heart transplant program at Memorial Regional Hospital

Eating watermelon reduces blood pressure in overweight individuals

Eating watermelon reduces blood pressure in overweight individuals

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

Cardinal Health agrees to acquire AccessClosure for $320 million

Cardinal Health agrees to acquire AccessClosure for $320 million

FDA allows CryoLife to begin PerClot clinical trial in the U.S.

FDA allows CryoLife to begin PerClot clinical trial in the U.S.

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Health Diagnostic Laboratory opens My HDL Hub health centers to prevent major chronic diseases

Health Diagnostic Laboratory opens My HDL Hub health centers to prevent major chronic diseases

Study of non-surgically implanted replacement pulmonary valve shows strong results

Study of non-surgically implanted replacement pulmonary valve shows strong results

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

Perioperative aspirin increases risk of serious bleeding after non-heart-related surgery

Perioperative aspirin increases risk of serious bleeding after non-heart-related surgery

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.